Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC ZYDUS LIFESCIENCES ALEMBIC/
ZYDUS LIFESCIENCES
 
P/E (TTM) x 28.1 29.0 96.7% View Chart
P/BV x 1.3 6.3 19.8% View Chart
Dividend Yield % 2.2 0.5 399.1%  

Financials

 ALEMBIC   ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    ALEMBIC
Mar-23
ZYDUS LIFESCIENCES
Mar-23
ALEMBIC/
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs87495 17.6%   
Low Rs56319 17.4%   
Sales per share (Unadj.) Rs5.0170.3 2.9%  
Earnings per share (Unadj.) Rs3.119.8 15.9%  
Cash flow per share (Unadj.) Rs3.426.9 12.6%  
Dividends per share (Unadj.) Rs2.206.00 36.7%  
Avg Dividend yield %3.11.5 209.5%  
Book value per share (Unadj.) Rs80.9173.0 46.8%  
Shares outstanding (eoy) m256.781,012.20 25.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x14.42.4 601.5%   
Avg P/E ratio x22.720.6 110.2%  
P/CF ratio (eoy) x21.015.1 138.5%  
Price / Book Value ratio x0.92.4 37.4%  
Dividend payout %70.130.3 231.0%   
Avg Mkt Cap Rs m18,298412,144 4.4%   
No. of employees `000NANA-   
Total wages/salary Rs m24024,564 1.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m1,272172,374 0.7%  
Other income Rs m6434,746 13.5%   
Total revenues Rs m1,915177,120 1.1%   
Gross profit Rs m29729,677 1.0%  
Depreciation Rs m677,227 0.9%   
Interest Rs m51,299 0.4%   
Profit before tax Rs m86825,897 3.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m625,878 1.1%   
Profit after tax Rs m80620,019 4.0%  
Gross profit margin %23.417.2 135.7%  
Effective tax rate %7.122.7 31.4%   
Net profit margin %63.411.6 545.5%  
BALANCE SHEET DATA
Current assets Rs m1,721100,082 1.7%   
Current liabilities Rs m83855,267 1.5%   
Net working cap to sales %69.426.0 267.0%  
Current ratio x2.11.8 113.4%  
Inventory Days Days5,03850 10,017.3%  
Debtors Days Days67394 719.3%  
Net fixed assets Rs m20,324144,776 14.0%   
Share capital Rs m5141,012 50.7%   
"Free" reserves Rs m20,267174,146 11.6%   
Net worth Rs m20,780175,158 11.9%   
Long term debt Rs m00-   
Total assets Rs m22,046244,940 9.0%  
Interest coverage x187.720.9 896.4%   
Debt to equity ratio x00-  
Sales to assets ratio x0.10.7 8.2%   
Return on assets %3.78.7 42.3%  
Return on equity %3.911.4 33.9%  
Return on capital %4.215.5 27.0%  
Exports to sales %1.239.2 3.1%   
Imports to sales %2.411.9 19.7%   
Exports (fob) Rs m1667,577 0.0%   
Imports (cif) Rs m3020,544 0.1%   
Fx inflow Rs m1667,577 0.0%   
Fx outflow Rs m3020,544 0.1%   
Net fx Rs m-1447,033 -0.0%   
CASH FLOW
From Operations Rs m38926,888 1.4%  
From Investments Rs m7311,712 0.6%  
From Financial Activity Rs m-464-44,004 1.1%  
Net Cashflow Rs m-2-5,338 0.0%  

Share Holding

Indian Promoters % 70.9 75.0 94.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.1 18.4 6.0%  
FIIs % 1.1 5.7 18.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 25.0 116.4%  
Shareholders   99,130 294,324 33.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    SUPRIYA LIFESCIENCE     


More on ALEMBIC vs Cadila Healthcare

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALEMBIC vs Cadila Healthcare Share Price Performance

Period ALEMBIC Cadila Healthcare S&P BSE HEALTHCARE
1-Day 0.23% 5.00% 0.58%
1-Month 11.20% 17.96% 3.13%
1-Year 47.76% 117.73% 55.61%
3-Year CAGR -5.74% 22.25% 13.89%
5-Year CAGR 19.78% 34.55% 21.73%

* Compound Annual Growth Rate

Here are more details on the ALEMBIC share price and the Cadila Healthcare share price.

Moving on to shareholding structures...

The promoters of ALEMBIC hold a 70.9% stake in the company. In case of Cadila Healthcare the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALEMBIC and the shareholding pattern of Cadila Healthcare.

Finally, a word on dividends...

In the most recent financial year, ALEMBIC paid a dividend of Rs 2.2 per share. This amounted to a Dividend Payout ratio of 70.1%.

Cadila Healthcare paid Rs 6.0, and its dividend payout ratio stood at 30.3%.

You may visit here to review the dividend history of ALEMBIC, and the dividend history of Cadila Healthcare.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Tops 74,000 in Mock Trading Session Today | HAL, Mazagon Dock, Bharat Dynamics Surge 5% | All Sectoral Indices in Green Sensex Tops 74,000 in Mock Trading Session Today | HAL, Mazagon Dock, Bharat Dynamics Surge 5% | All Sectoral Indices in Green(Closing)

Indian share markets ended the mock trading session on a positive note tracking strong global peers and FII inflows.